| Issuer | % of Class | Filed |
|---|---|---|
|
Korsana Biosciences, Inc.
13G
KRSA · 23255M303
|
6.1% |
9/16/2026
Event 9/9/2026
|
|
ProMIS Neurosciences, Inc.
13G/A
Amendment 1
PMN · 74346M505
|
7.8% |
8/13/2026
Event 6/30/2026
|
|
ProMIS Neurosciences, Inc.
13G
PMN · 74346M505
|
10.0% |
3/18/2026
Event 3/11/2026
|
|
MBX Biosciences
13G/A
Amendment 1
MBX · 55287L101
|
4.5% |
11/12/2025
Event 9/30/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.